Hung Andrew J, King Peggy, Schlegel Peter N
James Buchanan Brady Urology Foundation, Department of Urology, Center for Male Reproductive Medicine and Microsurgery, New York Presbyterian Hospital, Weill Medical College of Cornell University, New York, New York 10021, USA.
J Urol. 2007 Aug;178(2):608-12; discussion 612. doi: 10.1016/j.juro.2007.03.125. Epub 2007 Jun 13.
We evaluated the clinical characteristics of men with uniform testicular maturation arrest and nonobstructive azoospermia or severe oligospermia, including the frequency of genetic defects and outcome of intracytoplasmic sperm injection with or without testicular sperm extraction.
We identified a group of 32 men with nonobstructive azoospermia or severe oligospermia, uniform maturation arrest (single spermatogenic pattern on biopsy), and normal follicle-stimulating hormone (7.6 IU/l or less). These patients were identified from 150 intracytoplasmic sperm injection candidates with severe oligospermia (less than 10,000/cc) and 600 men with nonobstructive azoospermia undergoing attempted testicular sperm extraction-intracytoplasmic sperm injection between November 1995 and September 2006. These patients were characterized based on the frequency of genetic anomalies (karyotype or Y chromosome microdeletions). Rates of sperm retrieval by testicular sperm extraction, fertilization and pregnancy after ICSI were measured.
Genetic anomalies were more common (45%) in men with uniform maturation arrest and normal follicle-stimulating hormone than other men with nonobstructive azoospermia (17%) undergoing testicular sperm extraction at our center (p <0.001). They had a lower sperm retrieval rate with testicular sperm extraction compared to other nonobstructive azoospermia patients (41% vs 60%, p = 0.05). Fertilization rate (37%) and clinical pregnancy (13%) were significantly less common than in other men with nonobstructive azoospermia (54% and 49%, respectively, p <0.01).
Patients with uniform maturation arrest and normal follicle-stimulating hormone are a clinically definable subgroup of men with nonobstructive azoospermia that have different treatment outcomes. They have a higher incidence of chromosomal abnormalities and Y chromosome microdeletions compared to other men with nonobstructive azoospermia. Despite having normal follicle-stimulating hormone and typically normal testicular volume, sperm retrieval may be difficult and the chance of successful pregnancy is limited.
我们评估了患有均匀性睾丸成熟停滞以及非梗阻性无精子症或严重少精子症男性的临床特征,包括遗传缺陷的发生率以及卵胞浆内单精子注射(ICSI)联合或不联合睾丸精子提取(TESE)的结果。
我们确定了一组32名患有非梗阻性无精子症或严重少精子症、均匀性成熟停滞(活检显示单一生精模式)且卵泡刺激素水平正常(7.6 IU/l或更低)的男性。这些患者是从1995年11月至2006年9月期间150名严重少精子症(低于10,000/cc)的ICSI候选者以及600名接受TESE-ICSI尝试的非梗阻性无精子症男性中筛选出来的。根据遗传异常(核型或Y染色体微缺失)的发生率对这些患者进行特征描述。测量TESE取精率、ICSI后的受精率和妊娠率。
在我们中心,患有均匀性成熟停滞且卵泡刺激素水平正常的男性中,遗传异常更为常见(45%),高于其他接受TESE的非梗阻性无精子症男性(17%)(p<0.001)。与其他非梗阻性无精子症患者相比,他们通过TESE的取精率较低(41%对60%,p = 0.05)。受精率(37%)和临床妊娠率(13%)明显低于其他非梗阻性无精子症男性(分别为54%和49%,p<0.01)。
患有均匀性成熟停滞且卵泡刺激素水平正常的患者是临床上可定义的非梗阻性无精子症男性亚组,其治疗结果不同。与其他非梗阻性无精子症男性相比,他们染色体异常和Y染色体微缺失的发生率更高。尽管卵泡刺激素水平正常且睾丸体积通常正常,但取精可能困难,成功妊娠的机会有限。